HF
REGN icon

HRT Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

HRT Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-98,849
Closed -$67.1M – 3888
2025
Q3 		$55.6M Buy
98,849
+78,225
+379% +$44.2M 0.2% 58
2025
Q2 		$10.8M Sell
20,624
-2,875
-12% -$1.6M 0.05% 285
2025
Q1 		$14.9M Buy
23,499
+14,967
+175% +$10.3M 0.09% 159
2024
Q4 		$6.08M Buy
8,532
+4,696
+122% +$3.94M 0.03% 342
2024
Q3 		$4.03M Buy
+3,836
New +$4.27M 0.02% 560
2024
Q2 		– Sell
-11,058
Closed -$10.6M – 2945
2024
Q1 		$10.6M Buy
11,058
+4,992
+82% +$4.75M 0.07% 143
2023
Q4 		$5.33M Sell
6,066
-4,590
-43% -$3.78M 0.04% 283
2023
Q3 		$8.77M Buy
+10,656
New +$8.37M 0.09% 158
2023
Q1 		– Sell
-40,648
Closed -$30.7M – 3072
2022
Q4 		$29.3M Buy
+40,648
New +$30M 0.41% 32
2021
Q4 		– Sell
-17,847
Closed -$10.8M – 3922
2021
Q3 		$10.8M Buy
17,847
+3,896
+28% +$2.42M 0.07% 139
2021
Q2 		$7.79M Sell
13,951
-1,756
-11% -$890K 0.07% 218
2021
Q1 		$7.43M Buy
+15,707
New +$7.65M 0.08% 190
2020
Q1 		– Sell
-3,815
Closed -$1.43M – 1248
2019
Q4 		$1.43M Buy
3,815
+1,497
+65% +$504K 0.06% 244
2019
Q3 		$643K Buy
+2,318
New +$686K 0.03% 549
2018
Q4 		– Sell
-2,018
Closed -$815K – 727
2018
Q3 		$815K Buy
+2,018
New +$768K 0.13% 129
2018
Q2 		– Sell
-1,010
Closed -$347K – 355
2018
Q1 		$347K Buy
+1,010
New +$351K 0.17% 121
2015
Q4 		– Sell
-1,509
Closed -$701K – 110
2015
Q3 		$701K Buy
+1,509
New +$810K 0.6% 29

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HRT Financial's REGN Position: Q4 2025 in Review

HRT Financial sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 98,849 shares — an estimated $67.1M sold.

HRT Financial first reported a position in REGN in Q3 2015 and held it in 17 quarters. The position peaked at $55.6M in Q3 2025. 1,385 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • HRT Financial reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 98,849 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $67.1M.
  • HRT Financial first reported a position in Regeneron Pharmaceuticals in Q3 2015 and held it in 17 quarters.
  • HRT Financial's Regeneron Pharmaceuticals position peaked at $55.6M in Q3 2025.
  • 1,385 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.